A detailed history of Dimensional Fund Advisors LP transactions in Lensar, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 648,959 shares of LNSR stock, worth $5.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
648,959
Previous 657,412 1.29%
Holding current value
$5.61 Million
Previous $2.96 Million 0.47%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$3.99 - $5.44 $33,727 - $45,984
-8,453 Reduced 1.29%
648,959 $2.97 Million
Q2 2024

Aug 09, 2024

SELL
$3.0 - $4.88 $1,356 - $2,205
-452 Reduced 0.07%
657,412 $2.96 Million
Q1 2024

May 10, 2024

SELL
$3.25 - $5.0 $9,158 - $14,090
-2,818 Reduced 0.43%
657,864 $2.24 Million
Q3 2023

Nov 09, 2023

SELL
$3.02 - $4.45 $14,680 - $21,631
-4,861 Reduced 0.73%
660,682 $2.04 Million
Q1 2023

May 12, 2023

SELL
$2.19 - $3.27 $26,113 - $38,991
-11,924 Reduced 1.76%
665,543 $1.66 Million
Q4 2022

Feb 09, 2023

SELL
$2.7 - $5.9 $1,169 - $2,554
-433 Reduced 0.06%
677,467 $2.01 Million
Q3 2022

Nov 10, 2022

SELL
$4.94 - $7.0 $4,495 - $6,370
-910 Reduced 0.13%
677,900 $3.76 Million
Q2 2022

Aug 12, 2022

BUY
$6.15 - $7.94 $13,486 - $17,412
2,193 Added 0.32%
678,810 $4.42 Million
Q1 2022

May 13, 2022

SELL
$5.8 - $8.2 $1,490 - $2,107
-257 Reduced 0.04%
676,617 $5.01 Million
Q4 2021

Feb 09, 2022

SELL
$5.9 - $7.84 $26,550 - $35,280
-4,500 Reduced 0.66%
676,874 $4.03 Million
Q3 2021

Nov 12, 2021

BUY
$7.5 - $8.88 $6,960 - $8,240
928 Added 0.14%
681,374 $5.36 Million
Q2 2021

Aug 12, 2021

SELL
$6.87 - $8.66 $53,840 - $67,868
-7,837 Reduced 1.14%
680,446 $5.89 Million
Q1 2021

May 14, 2021

SELL
$6.28 - $9.56 $87,455 - $133,132
-13,926 Reduced 1.98%
688,283 $5 Million
Q4 2020

Feb 25, 2021

BUY
$6.7 - $12.2 $4.7 Million - $8.57 Million
702,209 New
702,209 $5.09 Million

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $95.3M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.